UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002972 |
|---|---|
| Receipt number | R000003606 |
| Scientific Title | Phase II study of sorafenib in patients with advanced hepatocellular carcinoma |
| Date of disclosure of the study information | 2010/01/05 |
| Last modified on | 2019/01/15 13:02:34 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/01/04 20:17:56 | ||
| 2 | Update | 2010/07/04 16:25:09 | Name of person sending information Organization Division name Address Institute |
|
| 3 | Update | 2012/01/04 11:33:48 | Recruitment status |
|
| 4 | Update | 2012/07/04 19:10:00 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2015/01/05 10:17:20 | Email Address Address TEL |
|
| 6 | Update | 2017/07/11 10:07:07 | Name of primary person or sponsor Organization Category of Funding Organization |
|
| 7 | Update | 2019/01/15 13:02:34 | Recruitment status Publication of results |
